3648-57-5

Usage

Uses

Used in Organic Synthesis:
4-(4-Chloro-phenyl)-tetrahydro-pyran-4-carboxylic acid is used as a building block in organic synthesis for the creation of more complex organic molecules. Its unique structure, including the p-chlorophenyl group and the tetrahydro-pyran ring, allows for the formation of various chemical bonds and reactions, facilitating the synthesis of a wide range of organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-(4-chloro-phenyl)-tetrahydro-pyran-4-carboxylic acid is used as a key intermediate in the development of new drugs. Its chemical properties and structural features make it a promising candidate for the synthesis of pharmaceutical compounds with potential therapeutic applications. Researchers can exploit its reactivity and functional groups to design and synthesize novel drug molecules with improved efficacy and selectivity.
Used in Agrochemical Development:
4-(4-Chloro-phenyl)-tetrahydro-pyran-4-carboxylic acid also has potential applications in the development of agrochemicals. Its unique structure and properties can be utilized to create new agrochemicals with enhanced performance, such as pesticides, herbicides, or insecticides. By incorporating 4-(4-CHLORO-PHENYL)-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID into the design of agrochemicals, researchers can potentially develop more effective and environmentally friendly solutions for agricultural challenges.

Upstream product

• 111-46-6 diethylene glycol 
• 140-53-4 p-chlorobenzyl cyanide 
• 3648-74-6 4-(4-chlorophenyl)tetrahydro-2H-pyran-4-carbonitrile 

Downstream Products

• 3648-75-7 4-(4-Chloro-phenyl)-tetrahydro-pyran-4-carbonyl chloride 
• 1035260-90-2 diethyl 2-(4-(4-chlorophenyl)-tetrahydro-2H-pyran-4-carbonyl)malonate 

Relevant academic research and scientific papers

CYCLIC AMINOALKYLCARBOXAMIDE DERIVATIVE

The present invention relates to a compound represented by the following formula (I), which is useful as an antiallergic agent and/or an anti-inflammatory agent, or a physiologically acceptable salt thereof and the like: wherein R1 and R2 are the same or different and each is an optionally substituted aryl group and the like, R3 is a hydrogen atom, a C1-6 alkyl group and the like, R4 and R5 are the same or different and each is a hydrogen atom, a halogen atom, a hydroxy group, a C1-6 alkyl group and the like, X is a single bond or -C(R6)(R7)-, R6 and R7 are the same or different and each is a hydrogen atom, a halogen atom, an optionally substituted C1-6 alkyl group and the like, or R6 and R7 optionally form, together with the carbon atom bonded thereto, an optionally substituted C3-8 cycloalkyl group and the like, ring group A is an azetidin-1-yl group and the like, m is 0, 1 or 2, and n is 0, 1 or 2.

NAPHTHALENONE COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF

Compounds of Formula (I) and Formula (II) are useful as inhibitors of HIF prolyl hydroxylases. Compounds of Formula(I) and Formula (II) have the following structures, where the definitions of the variables are provided herein.

Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof

One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various mammalian cellular receptors, including G-protein coupled receptors. A third aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for mammalian dopamine, muscarinic or serotonin receptors or transporters. Another aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for mammalian dopamine, muscarinic or serotonin receptors. The compounds of the present invention will also find use in the treatment of numerous ailments, conditions and diseases which afflict mammals, including but not limited to addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, Parkinson's disease, restless leg syndrome, sleeping disorders, attention deficit hyperactivity disorder, irritable bowel syndrome, premature ejaculation, menstrual dysphoria syndrome, urinary incontinence, inflammatory pain, neuropathic pain, Lesche-Nyhane disease, Wilson's disease, Tourette's syndrome, psychiatric disorders, stroke, senile dementia, peptic ulcers, pulmonary obstruction disorders, and asthma.